Rationalizing antibiotic use to limit antibiotic resistance in india

Indian Journal of Medical Research

Volumn 134, Issue 9, 2011, Pages 281-294

  Ganguly, Nirmal K ^a,b   Arora, N K ^c   Chandy, Sujith J ^d   Fairoze, Mohamed Nadeem ^e   Gill, J P S ^f   Gupta, Usha ^g   Hossain, Shah ^h   Joglekar, Sadhna ⁱ   Joshi, P C ^j   Kakkar, Manish ^k   Kotwani, Anita ^l   Rattan, Ashok ^m   Sudarshan, H ⁿ   Thomas, Kurien ^d   Wattal, Chand ^o   Easton, Ms Alice ^p   Laxminarayan, Ramanan ^q  

^a GARP India Working Group   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c Okhla Industrial Area   (India)

^d CHRISTIAN MEDICAL COLLEGE   (India)

^e VETERINARY COLLEGE   (India)

^f GURU ANGAD DEV VETERINARY AND ANIMAL SCIENCES UNIVERSITY   (India)

^g Delhi Society for Promotion of Rational Use of Drugs   (India)

^h National Centre for Disease Control   (India)

ⁱ GlaxoSmithKline Pharmaceuticals Ltd   (India)

^j UNIVERSITY OF DELHI   (India)

^k PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^l UNIVERSITY OF DELHI   (India)

^m Fortis Clinical Research Ltd   (India)

ⁿ Karuna Trust   (India)

^o SIR GANGA RAM HOSPITAL   (India)

^p Center for Disease Dynamics Economics and Policy   (India)

^q Institutional Area   (India)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; LINCOSAMIDE; MACROLIDE; OFLOXACIN; PENICILLIN G; QUINOLONE; STREPTOGRAMIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; DIAGNOSTIC TEST; DRUG USE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HOSPITAL INFECTION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; NONHUMAN; NOTE;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HEALTH POLICY; INDIA; PUBLIC POLICY;

EID: 80054728070     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Note

References (87)

1. World Health Organization. World Health Statistics. France; 2011.
2. Mathew JL. Pneumococcal vaccination in developing countries: where does science end and commerce begin? Vaccine 2009; 27: 4247-51.
3. Levine OS, Cherian T. Pneumococcal vaccination for Indian children. Indian Pediatr 2007; 44: 491-6.
4. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences of the United States of America. 1999; 96: 1152-6.
5. Laxminarayan R, Malani A, Howard D, Smith D. Extending the Cure. Policy responses to the growing threat of antibiotic resistance. Washington, DC; 2007 [updated 2007; cited]; Available fromhttp://www.rff.org/Publications/Pages/PublicationDetails.aspx?PublicationID=9575.
6. Kotwani A, Holloway K, Chaudhury RR. Methodology for surveillance of antimicrobials use among out-patients in Delhi. Indian J Med Res 2009; 129: 555-60.
7. Kotwani A, Holloway K. Trends in antibiotic use among outpatients in New Delhi, India. BMC Infect Dis 2011; 11: 99.
8. Bharuch B. Personal Communication: Data from IMS Health Information and Consulting Services-India. In: Laxminarayan R, editor. Courtesy of Pfizer; 2009.
9. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial agents Chemotherapy 2009; 53: 5046-54.
10. Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman R. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. J Assoc Physicians India 2010; 58: 147-9.
11. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
12. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11: 355-62.
13. Sinha M, Srinivasa H, Macaden R. Antibiotic resistance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res 2007; 126: 63-7.
14. Gaur A, Garg A, Prakash P, Anupurba S, Mohapatra TM. Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India. J Health Popul Nutr 2008; 26: 183-8.
15. Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prasad KJ. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. J Assoc Physicians India 2010; 58 (Suppl): S32-6.
16. Mehta A, Rosenthal VD, Mehta Y, Chakravarthy M, Todi SK, Sen N, et al. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007; 67: 168-74.
17. Shahid M, Malik A. Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients. Indian J Med Res 2005; 122: 324-9.
18. Kumari HB, Nagarathna S, Chandramuki A. Antimicrobial resistance pattern among aerobic gram-negative bacilli of lower respiratory tract specimens of intensive care unit patients in a neurocentre. Indian J Chest Dis Allied Sci 2007; 49: 19-22.
19. Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance. Int J Infect Dis 2008; 12: 256-64.
20. Mathai E, Chandy S, Thomas K, Antoniswamy B, Joseph I, Mathai M, et al. Antimicrobial resistance surveillance among commensal Escherichia coli in rural and urban areas in Southern India. Trop Med Int Health 2008; 13: 41-5.
21. Kaul S, Brahmadathan KN, Jagannati M, Sudarsanam TD, Pitchamuthu K, Abraham OC, et al. One year trends in the gram-negative bacterial antibiotic susceptibility patterns in a medical intensive care unit in South India. Indian J Med Microbiol 2007; 25: 230-5.
22. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL. Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrobial agents Chemother 2009; 53: 3280-4.
23. Chandel DS, Chaudhry R. Drug-resistant salmonella enterica Serotype Paratyphi A in India. Emerg Infect Dis 2000; 6: 420-1.
24. Kumar R, Gupta N. Multidrug-resistant typhoid fever. Indian J Pediatr 2007; 74: 39-42.
25. Sethi S, Sharma D, Mehta SD, Singh B, Smriti M, Kumar B, et al. Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India. Indian J Med Res 2006; 123: 707-10.
26. Narang P, Mendiratta DK, Deotale VS, Narang R. Changing patterns of Vibrio cholerae in sevagram between 1990 and 2005. Indian J Med Microbiol 2008; 26: 40-4.
27. Mani R, Pradhan S, Nagarathna S, Wasiulla R, Chandramuki A. Bacteriological profile of community acquired acute bacterial meningitis: a ten-year retrospective study in a tertiary neurocare centre in South India. Indian J Med Microbiol 2007; 25: 108-14.
28. Jain A, Shukla VK, Tiwari V, Kumar R. Antibiotic resistance pattern of group-a beta-hemolytic streptococci isolated from north Indian children. Indian J Med Sci 2008; 62: 392-6
29. Coles C, Rahmathullah L. Nasopharyngeal carriage of resistant pneumococci in young South Indian infants. Epidemiol Infect 2002; 129: 491-7.
30. Sekar R, Srivani R, Vignesh R, Kownhar H, Shankar EM. Low recovery rates of high-level aminoglycoside-resistant enterococci could be attributable to restricted usage of aminoglycosides in Indian settings. J Med Microbiol 2008; 57: 397-8.
31. Holloway K, Mathai E, Sorensen TL, Gray A. (US Agency for International Development). Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings. Report on five pilot projects. Geneva: World Health Organization; 2009.
32. Thomas K, Lalitha MK, Arora NK, Das B, Awasthi S, Amita J, et al. Invasive Bacterial Infectious Surveillance II (IBIS 2) Final Report. Vellore; [cited 2011 5 August]. Available from: http://www.inclentrust.org/resources/iphid/iidi/Annex 1-IBISI 2final.pdf.
33. Pulimood TB, Lalitha MK, Jesudason MV, Pandian R, Selwyn J, John TJ. The spectrum of antimicrobial resistance among methicillin resistant Staphylococcus aureus (MRSA) in a tertiary care centre in India. Indian J Med Res 1996; 103: 212-5.
34. Shankar CU, Harish BN, Kumar PMU, Navaneeth BV. Prevalence of methicillin resistant Staphylococcus aureus in JIPMER hospital. A preliminary report. Indian J Med Microbiol 1997; 15: 137-8.
35. Tyagi A, Kapil A, Singh P. Incidence of methicillin resistant Stahylococcus aureus (MRSA) in pus samples at a tertiary care hospital, AIIMS, New Delhi. J Indian Acad Clin Med 2008; 9: 33-5.
36. Vidhani S, Mehndiratta PL, Mathur MD. Study of methicillin resistant S. aureus (MRSA) isolates from high risk patients. Indian J Med Microbiol 2001; 19: 13-6.
37. Verma S, Joshi S, Chitnis V, Hemwani N, Chitnis D. Growing problem of methicillin resistant staphylococci-Indian scenario. Indian J Med Sci 2000; 54: 535-40.
38. Tahnkiwale SS, Roy S, Jalgaonkar SV. Methicillin resistance among isolates of Staphylococcus aureus: antibiotic sensitivity pattern & phage typing. Indian J Med Sci 2002; 56: 330-4.
39. Hanumanthappa AR, Chandrappa NR, Rajasekharappa MG. Prevalence of methicillin resistant Staphylococcus aureus in Karnataka. Indian J Pathol Microbiol 2003; 46: 129-32.
40. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM. Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 2003; 21: 49-51.
41. Mohanty S, Kapil A, Dhawan B, Das BK. Bacteriological and antimicrobial susceptibility profile of soft tissue infections from Northern India. Indian J Med Sci 2004; 58: 10-5.
42. Krishna BV, Patil AB, Chandrasekhar MR. Community-acquired methicillin-resistant Staphylococcus aureus infections in a south Indian city. Southeast Asian J Trop Med Public Health 2004; 35: 371-4.
43. Anbumani N, Kalyani M, Mallika M. Prevalence of Methicillin-Resistanct Staphylococcus aureus in a tertiary referral hospital in Chennai, South India. Ind J Pract Doc 2006; 3: 8-9.
44. Deep A, Goel N, Sikka R, Chaudhary U, Yadav S, A. G, et al. Quinupristin-dalfopristin resistance in gram-positive bacteria: experience from a tertiary care referral center in North India. J Infect Dis Antimicrob Agents 2008; 25: 117-21.
45. Tiwari HK, Sapkota D, Sen MR. High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India. Infec Drug Resist 2008; 1: 57-61.
46. Murugan S, Mani KR, Uma Devi P. Prevalence of methicillin resistant Staphylococcus aureus among diabetes patients with foot ulcers and their antimicrobial susceptibility pattern. J Clin Diagn Res 2008; 2: 979-84.
47. Majumder D, Bordoloi JS, Phukan AC, Mahanta J. Antimicrobial susceptibility pattern among methicillin resistant staphylococcus isolates in Assam. Indian J Med Microbiol 2001; 19: 138-40.
48. Kamat US, Ferreira A, Savio R, Motghare DD. Antimicrobial resistance among nosocomial isolates in a teaching hospital in Goa. Indian J Community Med 2008; 33: 89-92.
49. Arora B, Prabhat Ranjan K, Arora DR. Prevalence of methicillin-resistant Staphylococcus aureus in post operative infections in a referral hospital in Haryana, India. J Infect Dis Antimicrob Agents 2008; 25: 123-7.
50. Verghese S, Padmaja P, Sudha P, Vanitha V, Mathew T. Nasal carriage of methicillin resistant Staphylococcus aureus in a cardiovascular tertiary care centre and its detection by Lipovitellin Salt Mannitol Agar. Indian J Pathol Microbiol 1999; 42: 441-6.
51. Mehndiratta PL, Vidhani S, Mathur MD. A study on Staphylococcus aureus strains submitted to a reference laboratory. Indian J Med Res 2001; 114: 90-4.
52. Taneja N, Emmanuel R, Chari PS, Sharma M. A prospective study of hospital-acquired infections in burn patients at a tertiary care referral centre in North India. Burns 2004; 30: 665-9.
53. Mathur P, Kapil A, Das B. Nosocomial bacteraemia in intensive care unit patients of a tertiary care centre. Indian J Med Res 2005; 122: 305-8.
54. Kotwani A, Roy Chaudhury R, Holloway K. Conference Paper: Prescribing antibiotics for acute respiratory tract infections by primary care physicians in New Delhi, India. International Society of Pharmacoeconomics and Outcomes Research; 2010.
55. Kumar R, Indira K, Rizvi A, Rizvi T, Jeyaseelan L. Antibiotic prescribing practices in primary and secondary health care facilities in Uttar Pradesh, India. J Clin Pharm Ther 2008; 33: 625-34.
56. Radyowijati A, Haak H. Improving antibiotic use in low-income countries: an overview of evidence on determinants. Soc Sci Med 2003; 57: 733-44.
57. Kotwani A, Wattal C, Katewa S, Joshi PC, Holloway K. Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract 2010; 27: 684-90.
58. Sivagnanam G, Thirumalaikolundusubramanian P, Mohanasundaram J, Raaj AA, Namasivayam K, Rajaram S. A survey on current attitude of practicing physicians upon usage of antimicrobial agents in southern part of India. Med Gen Med 2004; 6: 1
59. Dua V, Kunin CM, White LV. The use of antimicrobial drugs in Nagpur, India. A window on medical care in a developing country. Soc Sci Med 1994; 38: 717-24.
60. Kotwani A, Wattal C, Joshi PC, Holloway K. Irrational use of antibiotics and role of the pharmacist: an insight from a qualitative study in New Delhi. J Clin Pharm Ther 2011; (In press).
61. Delhi Society for Promotion of Rational Use of Drugs. (WHO/SEARO). Promoting awareness amongst school children on rational use of drugs. Delhi; 2009.
62. Sharma R, Verma U. Self-medication among urban population of Jammu city. Indian J Pharmacol 2005; 37: 37-45.
63. Manna SK, Brahmane MP, Manna C, Batabyal K, Das R. Occurrence, virulence characteristics and antimicrobial resistance of Escherichia coli O157 in slaughtered cattle and diarrhoeic calves in West Bengal, India. Lett Appl Microbiol 2006; 43: 405-9.
64. Khachatourians GG. Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria. Can Med Assoc J 1998; 159: 1129-36.
65. Ministry of Health & Family Welfare. National Policy for Containment of Antimicrobial Resistance-India. 2011 [updated 2011; cited]. Available from: http://www.nicd.nic.in/ncdc_new/ab_policy.pdf.
66. Export Inspection Council of India. Approval and monitoring of processing/storing establishments for export: Egg products. New Delhi; 2007 [updated 2007; cited 2011 20 June]. Available from: http://www.eicindia.org/eic/inspection/egg.pdf.
67. FAO/OIE/WHO. Non-Human Antimicrobial Usage and Antimicrobial Resistance. Geneva; 2003 [updated 2003; cited 2011 June 20]. Available from: http://www.who.int/foodsafety/publications/micro/en/amr.pdfhttp://www.who.int/foodsafety/publications/micro/en/amr.pdf.
68. Arya G, Roy A. Serogroups, atypical biochemical characters, colicinogeny and antibiotic resistance pattern of shiga toxin-producing Escherichia coli isolated from diarrhoeic calves in Gujarat, India. Zoonoses Public Health 2008; 55: 89-98.
69. Times News Network. Antibiotics in most honey brands: Study. The Times of India. 2010 September 16. Available from: http://articles.timesofindia.indiatimes.com/2010-09-16/india/28225876_1_honey-brands-antibiotics-honey-samples.
70. Special Correspondent. Honey! It's sweet, yet comes with a sting. The Hindu. 2010 September 16; Front Page. Available from: http://www.hindu.com/2010/09/16/stories/2010091661730900.htm.
71. Honey, these popular brands are contaminated with antibiotics. Deccan Herald 2010 September 15; National. Available from: http://www.deccanherald.com/content/96888/honey-popular-brands-contaminated-antibiotics.html.
72. Johnson S, Jadon N, Mathur HB, Agarwal HC. Antibiotic residues in honey. New Delhi: Centre for Science and Environment; 2010.
73. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359: 1555-64.
74. IDSP. Integrated Disease Surveillance Project Annual Report, Final. New Delhi: Ministry of Health and Family Welfare; 2008.
75. Srivastava RK, Roy Chaudhury R, Ganguly NK, Bramhachari SK, Singh S, Guleria R, et al. National Policy for Containment of Antimicrobial Resistance-India: Ministry of Health & Family Welfare; 2011.
76. Rhinehart E, Goldmann DA, O'Rourke EJ. Adaptation of the Centers for Disease Control guidelines for the prevention of nosocomial infection in a pediatric intensive care unit in Jakarta, Indonesia. Am J Med 1991; 91: S213-20.
77. WHO. Surgical Safety Checklist. 1st ed. [cited 2011 5 August]. Available from: http://www.who.int/patientsafety/safesurgery/tools_resources/SSSL_Checklist_finalJun08.pdf.
78. Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat A-HS, Dellinger EP, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009; 360: 491-9.
79. Sinha K. MCI plans to send docs back to lecture halls. Times of India 2011 April 5.
80. Narayanan D. Tamil Nadu's efficient drug procurement system offers clues to fixing the glitches in the national health system. Forbes India 2010 July 27.
81. Kotwani A, Levinson L. Price components and access to medicines in Delhi, India. London: DFID; 2007.
82. Gupta YK, Sharma SK, Sidhu TS, Harit AK, Kanungo D, Shekhar C, et al. National List of Essential Medicines of India. 2011 [updated 2011; cited 2011 August 4]. Available from: http://cdsco.nic.in/National List of Essential Medicine-final copy.pdf.
83. Directorate General of Health Services, Ministry of Health & Family Welfare. National List of Essential Medicines. 2003 [updated 2003; cited 2011 5 August]. Available from: http://www.searo.who.int/LinkFiles/Essential_Drugs_and_Medicines_India.pdf.
84. Hogerzeil HV, Bimo MD, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, et al. Field tests for rational drug use in twelve developing countries. Lancet 1993; 342: 1408-10.
85. Hogerzeil HV, Walker GJ, Sallami AO, Fernando G. Impact of an essential drugs programme on availability and rational use of drugs. Lancet 1989; 1: 141-2.
86. Lindtjorn B. Essential drug list in a rural hospital. Does it have any influence on drug prescription? Trop Doct 1987; 17: 151-5.
87. Laxminarayan R, Ganguly NK. India's vaccine deficit: Why more than half of Indian children are not fully immunized, and what can-and should-be done. Health Aff (Millwood) 2011; 30: 1096-103.